Authors:
Simmons, ML
Armstrong, P
Califf, R
Barnathan, E
Hoynck, M
Scherer, J
Wallentin, L
Citation: Ml. Simmons et al., Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial, LANCET, 357(9272), 2001, pp. 1915-1924
Authors:
Szczech, LA
Reddan, DN
Owen, WF
Califf, R
Racz, M
Jones, RH
Hannan, EL
Citation: La. Szczech et al., Differential survival after coronary revascularization procedures among patients with renal insufficiency, KIDNEY INT, 60(1), 2001, pp. 292-299
Authors:
Cho, L
Topol, EJ
Balog, C
Foody, JM
Booth, JE
Cabot, C
Kleiman, NS
Tcheng, JE
Califf, R
Lincoff, MA
Citation: L. Cho et al., Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender - Pooled analysis from EPIC, EPILOG and EPISTENT trials, J AM COL C, 36(2), 2000, pp. 381-386
Authors:
Topol, CE
Califf, RM
Simes, RJ
Van de Werf, F
Diaz, R
Paolasso, E
Aylward, PE
Keech, A
Klein, W
Piegas, L
Tomov, I
Armstrong, PW
Widimsky, P
Grande, P
Halinen, M
Vahanian, A
Neuhaus, K
Dimas, AP
Preda, I
Kristinsson, A
Tzivoni, D
Ardissino, D
White, HD
Madsen, S
Sugrue, D
Sadowski, Z
Seabra-Gomes, R
Apetrei, E
Dalby, A
Betriu, A
Pfisterer, M
Verheugt, F
Fox, K
Bates, ER
Gibler, WB
Granger, CB
Harrington, RA
Hochman, JS
Holmes, DR
Kleiman, NS
Lee, KL
Moliterno, DJ
Newby, LK
Ohman, EM
Califf, R
Newby, K
Zillman, L
Lee, K
Lemons, P
McCourt, B
Campbell, C
Tardiff, B
Snapp, J
Bassett, K
Hodgson, P
Hannan, K
Kandzari, L
Hawkins, S
Hinman-Smith, E
McDougal, M
Raffetto, K
Thompson, D
Wehrle, T
Ange, C
Brown, R
Grissom, G
Heuckel, M
McCall, J
Pennachi, W
Spychala, M
Veasey, S
Pullium, M
Journey, T
Quintero, K
Mark, D
Davidson-Ray, L
Diner, L
Nelson, C
Sowers, C
Webb, G
Young, M
Bhapkar, M
Pacchiana, C
Sparapani, R
Tuttle, R
Weaver, D
Borzak, S
Douthat, L
Topol, E
Moliterno, D
Konczos, L
Baishnab, R
Baishnab, R
Bakos, A
Blashford, L
Bratsch, J
Brown, K
Cadorini, E
Carlson, J
Clemmons, P
DelValle, M
Drabik, M
Fu, G
Gates, K
Gibson, Y
Heil, L
Hill, N
Klancar, R
McHale, B
Montague, E
Pasca, N
Pergi, L
Randall, R
Rosso, R
Sankovich, K
Smith, D
Wisniewski, L
Witkowski, M
Zovkic, V
Alexander, K
Bhatt, D
Brener, S
Campbell, L
Cho, L
Cole, C
Deedy, M
Foody, J
Gassler, J
Ghaffari, S
Haas, G
Kapadia, S
Lauer, M
Lauer, MS
Lincoff, M
Lutton, S
Marso, S
Mukherjee, D
Patel, V
Penn, M
Robbins, M
Roe, M
Sila, C
Thamilarasan, M
Wagner, G
Armstrong, P
Bestilny, S
Van de Werf, F
Budts, W
Graux, S
Luyten, A
Simes, J
Keech, A
Kava, M
Bower, T
Chan, S
Crampton, L
Monro, C
Nayak, M
Parente, G
Riley, V
Wilton, D
Aylward, P
Dolan, S
Thomas, C
White, H
Scott, M
Frye, R
Alpert, J
Bertrand, M
Ryan, T
Fisher, L
Asarch, L
Smith, M
Lim, L
Bokslag, M
Chiu, P
Chung, J
Collins, S
Dougherty, C
Guimaraes, D
Hakim, Z
Mathieson, J
Montgomery, L
Novotny, B
Steiner, B
Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345
Authors:
Phillips, RS
Hamel, MB
Teno, JM
Soukup, J
Lynn, J
Califf, R
Vidaillet, H
Davis, RB
Bellamy, P
Goldman, L
Citation: Rs. Phillips et al., Patient race and decisions to withhold or withdraw life-sustaining treatments for seriously ill hospitalized adults, AM J MED, 108(1), 2000, pp. 14-19
Authors:
Pfeffer, MA
McMurray, J
Leizorovicz, A
Maggioni, AP
Rouleau, JL
Van de Werf, F
Henis, M
Neuhart, E
Gallo, P
Edwards, S
Sellers, MA
Velazquez, E
Califf, R
Citation: Ma. Pfeffer et al., Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design, AM HEART J, 140(5), 2000, pp. 727-734
Authors:
Topol, EJ
Easton, JD
Amarenco, P
Califf, R
Harrington, R
Graffagnino, C
Davis, S
Diener, HC
Ferguson, J
Fitzgerald, D
Shuaib, A
Koudstaal, PJ
Theroux, P
Van de Werf, F
Willerson, JT
Chan, R
Samuels, R
Ilson, B
Granett, J
Citation: Ej. Topol et al., Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial, AM HEART J, 139(6), 2000, pp. 927-933
Citation: R. Califf et M. Shah, Proceedings of a symposium - How should phase II trials in cardiovascular medicine be conducted? Hilton Head, South Carolina - October 3-4, 1997 - Introduction, AM HEART J, 139(4), 2000, pp. S131-S132
Authors:
Wenger, NS
Phillips, RS
Teno, JM
Oye, RK
Dawson, NV
Liu, HH
Califf, R
Layde, P
Hakim, R
Lynn, J
Citation: Ns. Wenger et al., Physician understanding of patient resuscitation preferences: Insights andclinical implications, J AM GER SO, 48(5), 2000, pp. S44-S51
Authors:
Puchalski, CM
Zhong, ZS
Jacobs, MM
Fox, E
Lynn, J
Harrold, J
Galanos, A
Phillips, RS
Califf, R
Teno, JM
Citation: Cm. Puchalski et al., Patients who want their family and physician to make resuscitation decisions for them: Observations from SUPPORT and HELP, J AM GER SO, 48(5), 2000, pp. S84-S90
Authors:
Van de Werf, F
Adgey, J
Ardissino, D
Armstrong, PW
Aylward, P
Barbash, G
Betriu, A
Binbrek, AS
Califf, R
Diaz, R
Fanebust, R
Fox, K
Granger, C
Heikkila, J
Husted, S
Jansky, P
Langer, A
Lupi, E
Maseri, A
Meyer, J
Mlczoch, J
Mocceti, D
Myburgh, D
Oto, A
Paolasso, E
Pehrsson, K
Seabra-Gomes, R
Soares-Piegas, L
Sugrue, D
Tendera, M
Topol, E
Toutouzas, P
Vahanian, A
Verheugt, F
Wallentin, L
White, H
Berioli, S
Bluhmki, E
Brower, R
Danays, T
Fox, NL
Girault, C
Goetz, G
Houbracken, K
Jakob, H
Kaye, J
Sarelin, H
Clow, FW
Hacke, W
von Kummer, L
Lesaffre, E
Bluhmki, E
Bogaerts, K
Munster, K
Scheys, I
Truyen, M
Clow, FW
Fox, KAA
Brower, R
Hallstrom, A
Jones, D
Maggioni, A
Weaver, D
Citation: F. Van De Werf et al., Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, LANCET, 354(9180), 1999, pp. 716-722